Results 121 to 130 of about 3,824 (132)
Some of the next articles are maybe not open access.
Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases
Nature Reviews Drug Discovery, 2012Charles A Dinarello +2 more
exaly
Brodalumab, an Anti–Interleukin-17–Receptor Antibody for Psoriasis
New England Journal of Medicine, 2012Ka Papp, Alan Menter, James G Krueger
exaly
Molecular cloning and expression of cDNAs for the human interleukin-2 receptor
Nature, 1984Warren J Leonard, Thomas A Waldmann
exaly
Inflammatory Bowel Disease and Mutations Affecting the Interleukin-10 Receptor
New England Journal of Medicine, 2009Erik-Oliver Glocker +2 more
exaly
Interleukin-36–Receptor Antagonist Deficiency and Generalized Pustular Psoriasis
New England Journal of Medicine, 2011Anne Puel +2 more
exaly
Interleukin-2–Receptor Blockade with Daclizumab to Prevent Acute Rejection in Renal Transplantation
New England Journal of Medicine, 1998Philip F Halloran
exaly
An Autoinflammatory Disease with Deficiency of the Interleukin-1–Receptor Antagonist
New England Journal of Medicine, 2009Ivona Aksentijevich +2 more
exaly

